ANZ Group Holdings Ltd
ANZ
Rio Tinto Ltd
RIO
BHP Group Ltd
BHP
Fortescue Ltd
FMG
Westpac Banking Corp
WBC
AU Stock MarketDetailed Quotes
IMC Immuron Ltd
- 0.069
- -0.001-1.43%
20min DelayTrading Mar 26 13:42 AET
15.81MMarket Cap-2.30P/E (Static)
0.069High0.069Low4.70KVolume0.069Open0.070Pre Close324.00Turnover0.13552wk High0.00%Turnover Ratio229.15MShares0.06952wk Low-0.032EPS TTM13.83MFloat Cap673.436Historical HighLossP/E (Static)200.50MShs Float0.050Historical Low-0.03EPS LYR0.00%Amplitude--Dividend TTM1.53P/B1Lot Size--Div YieldTTM
About Immuron Ltd Company
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.
Company Profile
SymbolIMC
Company NameImmuron Ltd
Founded1994
MarketASX
Employees7
Fiscal Year Ends06-30
AddressChapman Street Unit 10, 25-37
CityMelbourne
CountryAustralia
Zip Code3130
Phone+61 398245254
Websitehttps://www.immuron.com.au
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Steven Lydeamore
- Chief Executive Officer
- 599.14K
- Phillip A. Hains
- Chief Financial Officer and Secretary
- --
- Flavio Palumbo
- Chief Commercial Officer
- 347.61K
- Dr. Jerry Kanellos, PhD
- Chief Scientific Officer
- 359.25K
- Paul Brennan
- Chairman of the Board
- 153.60K
- Daniel Pollock
- Independent Director
- 127.65K
- Professor Ravi Savarirayan
- Independent Director
- 75.00K
- Dr. Jeannette Joughin
- Independent Director
- 7.55K